Laboratorios Farmaceuticos ROVI (ROVI) — Tangible Net Worth Ratio
Laboratorios Farmaceuticos ROVI (ROVI) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€632.80 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Laboratorios Farmaceuticos ROVI shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Laboratorios Farmaceuticos ROVI Tangible Net Worth Ratio (2003–2024)
This chart shows how Laboratorios Farmaceuticos ROVI's Tangible Net Worth Ratio has changed across 22 annual periods from 2003 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of €632.80 Million with intangible assets of €0.00 EUR. Also explore ROVI net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Laboratorios Farmaceuticos ROVI (2003–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Laboratorios Farmaceuticos ROVI from 2003 to 2024, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Laboratorios Farmaceuticos ROVI market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.2% | €581.54 Million | €33.95 Million | €832.02 Million | ▲ +0.4 pp |
| 2023 | 93.8% | €543.49 Million | €33.90 Million | €799.88 Million | ▲ +0.6 pp |
| 2022 | 93.1% | €521.38 Million | €35.74 Million | €878.70 Million | ▲ +1.3 pp |
| 2021 | 91.8% | €470.98 Million | €38.56 Million | €732.68 Million | ▲ +2.9 pp |
| 2020 | 88.9% | €373.70 Million | €41.41 Million | €574.44 Million | ▲ +2.9 pp |
| 2019 | 86.0% | €322.39 Million | €45.08 Million | €511.21 Million | ▼ -1.9 pp |
| 2018 | 87.9% | €287.47 Million | €34.65 Million | €402.70 Million | ▲ +2.1 pp |
| 2017 | 85.9% | €191.69 Million | €27.08 Million | €298.38 Million | ▼ -0.6 pp |
| 2016 | 86.4% | €183.41 Million | €24.87 Million | €287.85 Million | ▼ -2.1 pp |
| 2015 | 88.5% | €164.78 Million | €18.88 Million | €263.85 Million | ▼ -0.6 pp |
| 2014 | 89.1% | €158.47 Million | €17.21 Million | €261.32 Million | ▼ -0.8 pp |
| 2013 | 90.0% | €144.46 Million | €14.47 Million | €235.92 Million | ▼ -7.5 pp |
| 2012 | 97.5% | €126.45 Million | €3.18 Million | €222.36 Million | ▼ -0.1 pp |
| 2011 | 97.6% | €113.98 Million | €2.74 Million | €228.07 Million | ▼ -0.2 pp |
| 2010 | 97.8% | €104.13 Million | €2.29 Million | €212.89 Million | ▼ -1.6 pp |
| 2009 | 99.4% | €71.50 Million | €406.00K | €165.91 Million | ▼ -0.2 pp |
| 2008 | 99.6% | €48.44 Million | €172.00K | €120.55 Million | ▲ +1.1 pp |
| 2007 | 98.6% | €51.92 Million | €749.00K | €112.16 Million | ▲ +4.2 pp |
| 2006 | 94.3% | €25.81 Million | €1.47 Million | €76.04 Million | ▼ -5.7 pp |
| 2005 | 100.0% | €4.80 Trillion | €1.46 Million | €8.15 Trillion | ▲ +2644.4 pp |
| 2004 | -2544.4% | €2.92 Million | €77.11 Million | €7.88 Billion | ▼ -2637.7 pp |
| 2003 | 93.3% | €17.80 Million | €1.19 Million | €48.60 Million | — |